VSHP Webinar
November 12, 2026 – 12:00pm-1:00 pm
Wake-Up Call: Amantadine vs Modafinil in the Neurocritical Care Patient
Speaker:
Savannah Kangas, Pharm.D.
PGY1 Resident Pharmacist
Chippenham & Johnston-Willis Hospitals
Objectives for Pharmacists
At the completion of this activity, the participant will be able to:
- · Describe the common neuro deficit conditions
- · Define amantadine and modafinil and the MOA of the agents
- · Analyze the current pharmacotherapy used in awakening patient who have neurological deficits
- · Compare amantadine and modafinil studies
- · Provide recommendations for use of modafinil or amantadine based on presented evidence
Objectives for Pharmacy Technicians
At the conclusion of this activity, pharmacy technicians should be able to:
- 1. Identify common neurological conditions in neurocritical care patients that may affect consciousness and responsiveness.
- 2. Describe the basic mechanisms of action and common uses of amantadine and modafinil in patients with neurological deficits.
- 3. Recognize key medication-safety considerations for amantadine and modafinil, including dosing, adverse effects, monitoring needs, and the pharmacy technician’s role in supporting safe medication use.
Accreditation:
Virginia Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider for continuing pharmacy education and has assigned 1 contact hour (0.1 CEU) of continuing pharmacy education credits for participating in this activity. Participants of the session who complete the evaluation and provide accurate NABP e-Profile information will have their credit submitted to CPE Monitor as early as 1 day after the event and no later than 60 days after the event. Please know that if accurate e-Profile information is not provided within 60 days of the event, credit cannot be claimed after that time. The participant is accountable for verifying the accurate posting of CE credit to their CPE Monitor account within 60 days. Participants must participate in the activity and complete the course evaluation in its entirety to claim continuing pharmacy education credit.
ACPE UAN: 0108-0000-26-056-L01-P; 0108-0000-26-056-L01-T
Activity type: Application-based
This is a member service of VSHP. There is no charge for members to attend. Dues must be current to receive CE credit.
Non-members will be charged $20.
To register:
https://vshp.org/event-6885725
